Biological activities of the rice-derived Bevacizumab from transgenic rice callus and from the plasma of mice were detected using by Q-BEVA SHIKARI® ELISA kit.
1.
Chen L., et al., Efficient Production of a Bioactive
Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in
Transgenic Rice Callus. Frontiers in Plant Science August 2016 | Volume 7 |
Article 1156.
http://journal.frontiersin.org/article/10.3389/fpls.2016.01156/full
2. Bergen T.V., et al., Complementary effects of
bevacizumab and MMC in the improvement of surgical outcome after glaucoma
filtration surgery. Acta
Ophthalmologica 2015, 667-678.
https://www.ncbi.nlm.nih.gov/pubmed/25988844
No comments:
Post a Comment